| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 76.40B | 33.76B | 27.80B | 29.36B | 22.16B |
| Gross Profit | 31.81B | 33.76B | 27.80B | 29.36B | 22.16B |
| EBITDA | 19.14B | 0.00 | 0.00 | 18.35B | 14.54B |
| Net Income | 16.10B | 15.41B | 14.43B | 13.40B | 11.46B |
Balance Sheet | |||||
| Total Assets | 2.33T | 2.01T | 1.81T | 1.58T | 1.38T |
| Cash, Cash Equivalents and Short-Term Investments | 89.06B | 24.78B | 27.51B | 36.57B | 19.72B |
| Total Debt | 564.91B | 69.41B | 182.65B | 218.96B | 32.42B |
| Total Liabilities | 2.16T | 1.85T | 1.66T | 1.46T | 1.27T |
| Stockholders Equity | 167.95B | 157.45B | 142.98B | 119.61B | 108.56B |
Cash Flow | |||||
| Free Cash Flow | 27.96B | -159.44B | 89.96B | 49.63B | 36.19B |
| Operating Cash Flow | 28.82B | -158.87B | 90.58B | 50.19B | 37.01B |
| Investing Cash Flow | -313.75B | -69.00B | -60.80B | -64.96B | -36.19B |
| Financing Cash Flow | 278.90B | 227.02B | -33.63B | 28.28B | -9.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$39.38B | 3.55 | 9.70% | 5.69% | 11.27% | 12.75% | |
72 Outperform | HK$70.42B | 1.37 | 9.94% | 7.06% | -1.22% | 9.13% | |
71 Outperform | HK$87.24B | 4.35 | 9.19% | 5.16% | -1.33% | 7.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$33.68B | 3.69 | 12.90% | 4.45% | ― | ― | |
56 Neutral | HK$24.87B | 4.55 | 6.51% | 7.99% | -8.83% | -16.92% | |
46 Neutral | HK$15.75B | 1.92 | 3.77% | 1.89% | ― | ― |